Optimizing HER2-positive breast cancer therapy through neoadjuvant platforms: controversies and concepts
@article{TBCR53737, author = {Shuang-Ling Wu and Ying-Ying Xu}, title = {Optimizing HER2-positive breast cancer therapy through neoadjuvant platforms: controversies and concepts}, journal = {Translational Breast Cancer Research}, volume = {2}, number = {0}, year = {2021}, keywords = {}, abstract = {}, issn = {2218-6778}, url = {https://tbcr.amegroups.org/article/view/53737} }